NITO
Nexentis Technologies Inc.
Key Financials
Net Income
$-4004000
↑ 22.9%
Operating Income
$-4230000
↑ 2.1%
Revenue
$210000
↓ 20.3%
Gross Profit
$45000
↓ 78.4%
Total Liabilities
$4.7M
↑ 424.1%
Shareholders' Equity
$16.0M
↑ 237.1%
Total Assets
$20.4M
↑ 273.4%
Cash & Equivalents
$3.8M
↑ 75.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/14/2026 | View on SEC |
| 8-K | 4/30/2026 | View on SEC |
| EFFECT | 4/29/2026 | View on SEC |
| S-3 | 4/16/2026 | View on SEC |
| 8-K | 4/6/2026 | View on SEC |
| 10-K | 3/31/2026 | View on SEC |
| 4 | 3/26/2026 | View on SEC |
| 3 | 3/23/2026 | View on SEC |
| SCHEDULE 13G | 3/23/2026 | View on SEC |
| 8-K | 3/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NITO |
| Company Name | Nexentis Technologies Inc. |
| CIK | 1789192 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 972544561349 |